Health News
FDA says focused on tracking drugs after approval
ATLANTA - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.
Fatigue after early breast cancer often fades: study
NEW YORK (Reuters Health) - Many people treated for cancer are worn out for a time, but new findings suggest that long-lasting fatigue may be less common than thought -- at least for women with early-stage breast cancer.
Birth defects more common in IVF babies: study
- Babies conceived through certain fertility treatment techniques are about one-third more likely to have a birth defect than babies conceived without any extra help from technology, according to a review of several dozen studies.
Big regional differences in glaucoma diagnosis found
NEW YORK (Reuters Health) - A new analysis of Medicare records finds dramatic differences across the U.S. in rates of new glaucoma diagnoses, suggesting the eye disease is likely being overdiagnosed in some regions and underdiagnosed in others, researchers said.
FDA says nanotech may need extra safety tests
WASHINGTON - U.S. health regulators said consumer products that use nanotechnology may have unknown effects on the human body, and advised food and cosmetic companies to further study the safety of these tiny particles.
Everest climbers in test for keys to heart treatment
KATHMANDU - A team of U.S. scientists departed on Friday to conduct research on Mount Everest climbers in an effort to further knowledge of the cardiovascular system at extreme altitudes and help improve treatment for heart and lung patients.
Measles cases reached 15-year high in 2011: CDC
ATLANTA - Measles cases in the United States hit a 15-year high in 2011, with 90 percent of the cases traced to other countries with lower immunization rates, the Centers for Disease Control and Prevention reported.
Statins don't reduce melanoma risk: study
NEW YORK (Reuters Health) - Despite earlier indications that people taking statins might have a reduced risk of developing melanoma, a large new study of women finds the popular cholesterol-lowering drugs do nothing to prevent the deadly skin cancer.
Fish oil supplements don't help MS patients: study
NEW YORK (Reuters Health) - Many people with multiple sclerosis take fish oil pills with the hope of keeping neurological symptoms from getting worse, but a new study suggests the extra omega-3 fatty acids may not be doing them any good.
University of Colorado clamps down on "pot fest" but many light up
BOULDER, Colo. - The University of Colorado sought on Friday to clamp down on a huge annual marijuana fest, but after initially restricting access to the school, police later stood back and watched hundreds of people light up in a campus field.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
